share_log

Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

SEC announcement ·  May 13 16:22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more